Evelo Biosciences, Inc. (EVLO)

Evelo Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	29.91	31.75	22.27	23.23	18.22	7.57	3.89
Research & Development	78.55	83.64	69.62	63.13	39.89	19.96	9.13
Other Operating Expenses	0.06	0.49	-1.37	1.08	1.16	-0.3	-0.02
Operating Expenses	108.47	115.4	91.89	86.36	58.1	27.53	13.03
Operating Income	-108.47	-115.4	-91.89	-86.36	-58.1	-27.53	-13.03
Interest Income	0	0	0	0	0	0	0
Interest Expense	4.67	3.61	-2.11	1.05	1.56	0	0
Other Expense / Income	0.46	2.74	3.48	-1.93	-2.72	0.3	0.02
Pretax Income	-113.6	-121.75	-93.26	-85.47	-56.95	-28.05	-13.33
Income Tax	0.93	0.43	0.41	0.19	-3.09	0.22	0.29
Net Income	-114.53	-122.18	-93.67	-85.66	-53.85	-28.05	-13.33
Shares Outstanding (Basic)	4	3	2	2	1	0	0
Shares Outstanding (Diluted)	4	3	2	2	1	0	0
Shares Change	64.75%	34.02%	23.25%	46.46%	483.10%	32.32%	-
EPS (Basic)	-26.28	-46.18	-47.45	-53.49	-49.25	-182.00	-105.67
EPS (Diluted)	-26.28	-46.18	-47.45	-53.49	-49.25	-182.00	-105.67
Free Cash Flow	-101.86	-98.24	-74.38	-75.01	-52.74	-25.01	-13.56
Free Cash Flow Per Share	-23.37	-37.14	-37.68	-46.84	-48.23	-133.34	-95.70
EBITDA	-108.41	-114.91	-91.89	-86.36	-58.1	-26.7	-12.53
Depreciation & Amortization	2.06	2.22	2.03	1.76	1.94	0.83	0.5
EBIT	-110.47	-117.13	-93.91	-88.12	-60.04	-27.53	-13.03

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.